Results 101 to 110 of about 508,210 (220)

Patent Foramen Ovale: Epidemiology, Risk Factors, Pathophysiology, Clinical Features, Diagnosis, and Management

open access: yesMedComm, Volume 7, Issue 9, September 2026.
The clinical manifestations of PFO. Although the majority of PFOs are benign and asymptomatic, they can present with a variety of clinical manifestations, or coexisting with other diseases and aggravating their symptoms, including cerebral diseases (such as CS, epilepsy, TIA, or migraine), systemic embolism (such as embolism in renal artery, coronary ...
Linlin Meng   +6 more
wiley   +1 more source

Blood pressure, hypertension, and the risk of aortic aneurysm in the UK Biobank

open access: yesBMC Cardiovascular Disorders
Background Although an association between elevated blood pressure and risk of aortic aneurysm is established, few studies have investigated the association with aortic aneurysm subtypes.
Rida E.Z. Naqvi   +6 more
doaj   +1 more source

TEVAR for ruptured descending thoracic aortic aneurysm: case report

open access: yesJornal Vascular Brasileiro
A ruptured descending thoracic aortic aneurysm (rDTAA) is a life-threatening condition associated with high morbidity and mortality. Endovascular treatment for rDTAA promotes effective aneurysm exclusion with a minimally invasive approach.
Sthefano Atique Gabriel   +4 more
doaj   +1 more source

Evidence of a Protective Effect of Metformin on Abdominal Aortic Aneurysm Risk: Insights From an Observational Study and Mendelian Randomisation Analysis Using Putative Metformin Targets

open access: yesAnnals of Human Genetics, Volume 90, Issue 5, Page 294-302, September 2026.
ABSTRACT Aims There is no proven treatment to prevent the growth or rupture of abdominal aortic aneurysm (AAA). As an aneurysm enlarges over time, the risk of fatal aortic rupture increases. Metformin, a drug usually prescribed to treat Type 2 diabetes, has previously been associated with reduced AAA risk in observational studies. Our aim was to assess
Katie Louise Saxby   +5 more
wiley   +1 more source

Thoracic aortic aneurysm [PDF]

open access: yesVascular Medicine, 2018
Maya J, Salameh   +2 more
openaire   +2 more sources

Targeting m6A Modifications Regulating Ferroptosis Offers Novel Therapy in Diseases

open access: yesCell Proliferation, Volume 59, Issue 9, September 2026.
m6A RNA modification regulates ferroptosis by balancing iron metabolism, lipid peroxidation, and antioxidant defenses. Dysregulated m6A signaling disrupts pro‐ and anti‐ferroptotic factors, leading to excess ROS, Fe3+ accumulation, and lipid peroxidation–driven cell death. Targeting m6A‐mediated ferroptotic regulation represents a promising therapeutic
Lida Du   +7 more
wiley   +1 more source

Successful treatment of mycotic thoracic aortic aneurysm in collaboration with cardiovascular and general thoracic surgeons

open access: yes, 2014
We report a rare case of ruptured mycotic thoracic aortic aneurysm that required almost one month for correct diagnosis. A 71-year-old woman who had hemoptysis for several weeks was initially suspected to have lung cancer based on several examinations ...
Nagayasu, Takeshi   +7 more
core  

Endovascular Repair for Thoracic Aortic Pathologies—Early and Midterm Results

open access: yesAsian Journal of Surgery, 2009
To assess the early and midterm results of endovascular stent graft repair in patients with thoracic aortic pathologies. Methods: Between March 2000 and December 2005, 44 consecutive patients undergoing endovascular repair for 45 thoracic aortic lesions ...
Albert C.W. Ting   +5 more
doaj   +1 more source

Cellular phenotype transformation occurs during thoracic aortic aneurysm development [PDF]

open access: yes, 2010
ObjectiveThoracic aortic aneurysms result from dysregulated remodeling of the vascular extracellular matrix, which may occur as a result of altered resident cellular function.
Chang, Eileen I.   +7 more
core   +1 more source

Gastric pseudoaneurysm in the setting of Loey’s Dietz Syndrome [PDF]

open access: yes, 2012
Loey’s Dietz syndrome is a disorder of connective tissue caused by a mutation in the genes that encode transforming growth factor (TGF) beta receptor 1 and 2.
Johston, Troy Alan, Likes, Maggie L.
core  

Home - About - Disclaimer - Privacy